InvestorsHub Logo
Followers 0
Posts 29
Boards Moderated 0
Alias Born 01/04/2013

Re: None

Thursday, 01/10/2013 10:31:23 AM

Thursday, January 10, 2013 10:31:23 AM

Post# of 130508
RBCC is wasting no time in seeking out new projects that could speed unparalleled gains. It’s finalizing a joint venture with Amarantus BioSciences, Inc.’s (OTCBB: AMBS) to develop and market new therapies and treatments for both traumatic injuries and neurological diseases. Many of these innovations are already in development. The company is also targeting new projects that exhibit short paths to marketability in order to grow business as quickly as possible—and provide ample opportunities for investors to cash in.